Waltham, MA · Founded 2018 · Privately Held (backing)
Developer of novel liposomal formulations of antibacterial drugs intended to treat tuberculosis. Akagera Medicines is based in Waltham, MA and was founded in 2018. Its last reported valuation was $345 million in Jan 2025. It has raised $62.2 million.
Last reported valuation
$345.0M
Oct 2026
Priced at
—
Total raised
$62.2M
Last round
—
Cap table — not yet on record
Akagera Medicines's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Akagera Medicines with a free account
·Watch Akagera Medicines: the Monday email on marks, rounds and moves
